Quality of life in children and adolescents after treatment for acute lymphoblastic leukemia according to the NOPHO ALL2008 protocol.
Nina MogensenUlrika KreicbergsBirgitte Klug AlbertsenPäivi M LähteenmäkiMats HeymanArja HarilaPublished in: Pediatric blood & cancer (2024)
Self-reported HRQoL was similar to reference population. The most important determinant for HRQoL after end of ALL treatment was parent-reported toxicity during treatment. Thus, minimizing complications is an obvious focus for future treatment protocols.